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Abstract Drosomycin is a 44-residue antifungal peptide with parallel on recombinant and native drosomycin using enzy- 
four intramolecular disulfide bridges which have been isolated matic methods, automated microsequencing and mass spec- 
from immune-challenged Drosophila. To produce adequate trometry with a total of only 1 ~tg (200 pmol) per peptide. 
amounts of this peptide for 3D-structure analysis, studies on These results emphasize that the combination of enzymatic 
the mode of action and activity spectrum, we expressed a cleavage followed by matrix-assisted laser desorption mass 
synthetic eDNA in Saccharomyces cerevisiae. For this purpose, spectrometry measurement and Edman degradation provide 
we used the mating factor a gene and concomitantly over- a rapid and sensitive method for determination of disulfide 
expressed the KEX2 gene to increase the yield of fully processed bridges on minute amounts of peptides, as already described 
drosomycin. Using a combination of Edman degradation and [4,5]. The position of the disulfide bridges was found to be 
mass spectrometry, we show that drosomycin shares the same identical to that reported for plant defensins, reinforcing the 
array of intramolecular disulfide bridges than plant defensins, in idea that these molecules could be homologous. We have also 
addition to their sequence similarities. 
extended, with recombinant drosomycin, our previous tudies 
Key words." Antifungal peptide; Yeast expression; on the activity spectrum of this antifungal peptide. 
Mass spectrometry; Disulfide array 
2. Materials and methods 
2.1. Strains and media 
1. Introduction The S. cerevisiae strain TGY 48-1 used for drosomycin expression 
was described in [6]. Yeast complete medium was YPG (yeast extract 
Insects are particularly resistant o microbial infections. 1%, peptone 1%, glucose 2%). Yeast cells were transformed using the 
lithium acetate method [7] and transformants were selected on YNBG 
Their host defense involves the rapid and transient synthesis medium (yeast nitrogen base 0.67%, glucose 1%) supplemented with 
of small-sized cationic peptides with antibacterial nd/or anti- 0.5% casamino acids, lacking uracil. The Escherichia coli media and 
fungal properties. The peptides are produced in the fat body cloning procedures were from standard methods [8]. 
and secreted into the hemolymph, where they oppose the pro- 
liferation of microorganisms (reviewed in [1]). Drosomycin, a 2.2. Plasmids 
44-residue cysteine-rich peptide with potent antifungal activ- The expression block contains the MF~I promoter and preprose- 
quence with a silent mutation in 3' encoding a HindIII site to allow an 
ity, was isolated from immune-challenged adults of  Drosophila in-frame fusion of the coding sequences. It was subcloned from 
[2]. Interestingly, this peptide shares equence similarities with pTG1895 [6] into an M13 phage, yielding M13JM132, from which 
plant defensins, a group of antifungal peptides which partici- it can be mobilized as an SphI-BamHI fragment. The yeast/E, coli 
pate in the host defense of plants [3]. As plant defensins, shuttle vector pTG3828 has been described [9]. A 7 kb genomic frag- 
ment containing the KEX2 gene was cloned by complementation in S. drosomycin has eight cysteines engaged in four intramolecular cerevisiae and a BamHI site was created by site-directed mutagenesis 
disulfide bridges. It is surmised that the presence of these four 220 bp downstream of the ORF encoding the endoprotease (Achstet- 
bridges in the 44-residue peptide confers a highly compact ter, T. and Ngyen, M., unpublished). Finally, the 3475 bp XhoI-Bam- 
structure, accounting for the remarkable resistance of droso- HI fragment containing the full-length KEX2 gene was blunt-end 
mycin to protease and heat treatments, ligated into the unique EcoRI site of pTG3828 to obtain pTG4812 
in which transcription of KEX2 is counterclockwise. 
Drosophila is a small insect, which hampers the isolation of 
acceptable amounts of native drosomycin for 3D-structure 2.3. Synthetic gene construction and expression cassette assembly 
determination by NMR and detailed studies on its mode of A synthetic gene ncoding the 44-residue drosomycin, N-terminally 
action and activity spectrum. To overcome this problem, and flanked by the last five amino acids of the MF~I proregion, was 
in view of the interest in drosomycin i  both basic and applied synthesized by elongation of the two annealed oligonucleotides 
research, we have expressed under appropriate conditions its DRO-1 (5'GCGCGCAAGCTTGGACAAGAGGACTGCCTGTCC- 
GGAAGATACAAGGGTCCCTGTGCCTGGACAACGAGACCT- 
eDNA in Saccharomyces eerevisiae. The recombinant peptide GTCGTCGTGTGTGCAAGGAGGAGGGA3') and DRO-2 (5'GC- 
was purified to homogeneity and found to have the same AGCACACACGTTCCTCCTCCCTGCGAGGTCACCGGTGACG- 
chromatographic behaviour and biological activity as the na- TCGGGGTCAGACTTCACGACCACGCTTCCTACGATTCCTA- 
tive molecule. We have established the disulfide bridges in GGCGCGCG3') with the large (Klenow) fragment of DNA 
polymerase I. The resulting 169 bp fragment (Fig. 1A) was digested 
by HindIII and BamHI, ligated into M13JM132, yielding M13JM575, 
*Corresponding author. Fax: (33) 88 60 69 22. and sequenced using a T7 sequencing kit (Pharmacia). The expression 
E-mail: bulet@astorg.u-strasbg.fr cassette (Fig. 1B) was cloned as a 1.4 kb SphI-BamHI fragment in the 
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yeast/E, coli shuttle vectors pTG3828 or pTG4812, yielding the two 3. Results 
expression plasmids pJM576 and pJM600, respectively. 
To allow secretion of drosomycin by S. cerevisiae, the pep- 
2.4. Transformant product analysis tide coding sequence was fused with the preprosequence of the 
Transformed cells were grown overnight in 10 ml of selective me- yeast mating factor MF~I  gene. Expression is directed by the 
dium at 30°C. After centrifugation (12000xg, 30 min, 4°C), the 
supernatant was acidified to pH 5.2 with acetic acid and subjected strong MFcd  promoter and the fusion protein is expected to 
to solid-phase xtraction by reversed-phase chromatography ona Sep- be C-terminally cleaved after the basic dipeptide Lys-Arg of 
Pak Cxs cartridge (Waters) equilibrated with acidified water (TFA the MF~I  spacer peptide by the Kex2 endopeptidase, releas- 
0.05%). Elution was performed stepwise with solutions of 10% and ing mature drosomycin into the culture medium [11,12]. We 
30% acetonitrile in acidified water. The 30% fraction was concentrated 
constructed a synthetic gene where 15 nucleotides correspond- under vacuum (Savant) diluted in MilliQ water (Millipore) and ap- 
plied onto an Aquapore OD300 C]s column (220×4.6 ram, Brownlee) ing to the triplets 81-85 of the MFcxl prosequence were added 
equilibrated with acidified water. Elution was performed with a linear 5' to the mature drosomycin coding sequence, generating a
gradient of 7 57%, acetonitrile in acidified water over 90 min at a flow HindIII site necessary to obtain an in-frame fusion with the 
rate of 1 ml/min, prosequence. The drosomycin expression block was cloned 
into pTG3828, yielding pJM576. Yeasts were transformed 
2.5. Large-scalepurifieation f recombinant drosomycin either by the drosomycin expression vector pJM576 or by 
10 ml of an overnight culture of the selected transformant were pTG3828 as a control. The cell-free culture supernatant was 
used to inoculate 500 ml of selective medium. After 48 h incubation 
at 30°C under vigorous shaking, the culture (OD600: 9.5) was centri- subjected to solid-phase extraction and the fraction eluted 
fuged (12000×g, 30 rnin, 4°C) and the supernatant subjected to 30 with 30% acetonitrile was analyzed by reversed-phase 
rain heat treatment at 100°C and centrifuged again. The supernatant, HPLC. An absorpt ion peak, eluting at 26% acetonitrile, was 
containing the recombinant drosomycin, was acidified with acetic acid detected in yeast cultures carrying pJM576, but was absent in 
to pH 3 and subjected to solid-phase xtraction on an open column 
the control experiment. The material present in this absorp- filled with C1~ reversed-phase (preparative Cls 125 A, 6 g of phase/500 
ml of supernatant) equilibrated with acidified water. Elution was per- tion peak exhibited strong antifungal activity against N. cras- 
formed stepwise with solutions of 15 and 30% acetonitrile in acidified sa and B. cinerea and was subjected to CZE. The electropher- 
water. The fraction eluted with 30% acetonitrile was lyophilized, re- ogram revealed the existence of four expression products, in 
constituted in water and applied onto a preparative reversed-phase unequal amounts (data not shown). This fraction subjected to 
column (Aquapore ODS 20 ~tm, 250x 10 mm, Brownlee). Elution 
was performed with a linear gradient of 7-57% acetonitrile in acidified MALDI -TOF mass spectrometry analysis yielded four distinct 
water over 90 min at a flow rate of 5 ml/min. After lyophilization, masses corresponding to correctly matured drosomycin 
drosomycin was purified by ion-exchange chromatography on a ca- (4889.7 Da) accounting for 25% of the total, plus three N- 
tion column (Aquapore cation 20 ~tm, 250x 10 ram, Brownlee) equili- terminally extended expression products consisting of droso- 
brated in 50 mM ammonium acetate buffer pH 5.2. For elution, a mycin with either a 14-residue N-terminal extension (6373.0 
gradient of 0-100% NaC1 (1 M) in ammonium acetate buffer was used 
over 60 min at a flow rate of 4.5 ml/min. The column effluent was Da), a 9-residue extension (5903.4 Da) or a 7-residue exten- 
monitored by the absorbance at225 nm. Finally, the fraction contain- sion (5645.1 Da). All these residues correspond to the C-ter- 
ing drosomycin was desalted by reversed-phase HPLC, lyophilised minal amino acids of the MFcd  prosequence. Their presence 
and kept as dry powder, in this peptide obviously results from incomplete maturat ion 
of recombinant drosomycin (see Section 4). 
2.6. CZE and MALDI-TOF-MS To improve this yield of mature drosomycin (25%), we co- 
Capillary zone electrophoresis (CZE) and matrix-assisted laser de- expressed rosomycin with the Kex2 endoprotease by insert- 
sorption/ionisation time-of-flight mass spectrometry (MALDI-TOF- 
MS) were performed as described in [10]. ing the previously described expression cassette from 
M13JM575 into pTG4812, which carries a full length copy 
of the KEX2 gene. The resulting drosomycin/KEX2 expression 
2. 7. AntiJungal assay 
The antifungal assays were as described in [2] with the following 
fungal strains: Alternaria brassicola (MUCL 20297), Fusarium culmo- 
rum (IMI 180420), Neurospora erassa (CBS 327-54), and Botrytis cine- A 
rea (MUCL 30158), all gifts from W.F. Broekaert (Janssens Labora- . ,~o , i r  
tory of Genetics, Leuven, Belgium) and F oxysporum, F. oxysporum °~7,°%~c~%~;~%~L~%~;~Z~:Z~%~;~ ~® 
meloni, Stemphylium, Verticillium, B. petunia and A. dauci were from . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
the Soci~t~ Clause. ~"' 
s ~ s s c ~ c ,  ~ s L ~ c . C ~ s C 
2.8. Assignment of the disulfide bridges B 
Drosomycin (100 I.tg) was incubated with a combination of endo- ~ ~ ~, ~: 
proteinase GIu-C and endoproteinase Lys-C (Boehringer, Mannheim) ~ ~ ~ ~ e~ ~ ~ ~ • ~ ~ . . . . . . .  
at a peptide/enzyme ratio of 100:10 (w/w) and 100:5 (w/w), respec- I I  I I I  I I I  l:3"zv,~p~p,,,~q . . . . .  
tively. Digestion was performed in a mixture of two buffers: 25 mM 
Tris-HC1, pH 8.5, 1 mM EDTA and 25 mM ammonium carbonate, ~ ~ ...... ycl . . . . . .  ~p~ 
pH 7.8, for 16 h at 25°C. The digestion was stopped by acidification Fig. 1. (A) Sequence of the synthetic gene encoding the 44 residues 
with 0.1% TFA. Separation of peptide fragments was performed onto of mature drosomycin. The gene was fused to the last five amino 
an Aquapore RP300 Ca reversed-phase column (220X4.6 mm, 
Brownlee) with a linear gradient of 2-80% acetonitrile in acidified acids of the MFal  proregion (italics). The sequences of the two oli- 
water over 120 min at a flow rate of 1 ml/min at 40°C. gonucleotides (DRO-1, sense; DRO-2, antisense) used for the con- 
struction are underlined. The 169 bp sequence obtained after Kle- 
now elongation of these two annealed oligonucleotides ( ee Section 
2.9. Microsequence analysis 2) harbours a HindlII restriction site which enables in-frame fusion 
Automated Edman degradation of the purified peptides and detec- with the MFal proregion in the expression cassette. The BamHI 
tion of the phenylthiohydantoin derivatives were performed on a site located after the stop codon is also mentioned. (B) Structure 
pulse-liquid automatic sequenator (Applied Biosystems model 473A). and restriction map of the 1.4 kb drosomycin expression cassette. 
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Fig. 2. Analysis of the recombinant drosomycin proteolysis products. Recombinant drosomycin digested by a combination of endoproteinases 
Glu-C and Lys-C was submitted to reversed-phase HPLC. Elution was performed with a linear gradient of 2-80% acetonitrile inacidified water 
(dotted line) and absorbance was monitored at 225 nm (full line). Peaks 1 3 were analyzed MALDI-TOF mass pectrometry and sequenced by 
Edman degradation. Each inset shows the m/z values obtained and the sequence of the corresponding fragments. X labels the elution peak con- 
taining a mixture of masses which could not be associated to any fragment. E denotes the elution peak containing the enzymes. * designates 
the elution peak containing undigested drosomycin. 
plasmid is pJM600. The cell-free culture media of yeasts trans- cillium, 0.6-1.2 gM against Sternphylium, 1.2-2.5 gM against 
formed with pJM600, or pTG4812 as control, were submitted F. oxysporum L. to 2.5 5 p.M against F. oxysporum meloni. In 
to the same treatment as above. Again, the strong absorption contrast, low activity was found against A. dauci (MIC > 20 
peak eluting at 26% acetonitrile exhibited antifungal activity, gM). 
It was shown by CZE and mass spectrometry analysis to Knowing that drosomycin shares equence similarities with 
contain 90% of mature drosomycin (4890.0 Da) and 10% of Raphanus ativus defensin [2], the disulfide array of which was 
a N-terminally extended peptide (5645.1 Da). determined by NMR studies [13], we assumed that the posi- 
After solid-phase xtraction and an initial purification step tion of the disulfide bridges was identical in drosomycin and 
of the 30% acetonitrile fraction by preparative r versed-phase plant defensin, and selected endoproteinase Glu-C and endo- 
chromatography, the partially purified antifungal material proteinase Lys-C to digest 100 gg of recombinant drosomycin. 
was applied on a preparative cation exchange column (see The digestion mixture was subjected to HPLC purification. It
Section 2). The mature drosomycin fraction, eluting at ap- 
prox. 250 mM NaCI, was desalted by reversed-phase HPLC 
and lyophilised. CZE confirmed that the mature peptide had I [ [ I ] ] l  ] 
been purified to homogeneity. The identity of drosomycin was ~,.,o.,0,, DCL--SGRYKaPCAWDSErC~VC-KEEGRSSGHC---SPSZrCWCEG-C 
ascertained by mass spectrometry analysis. The specific anti- 
..-AFP, Z gCe2VgS GTW S ~VC G - - N._Na_C_K_~_QC_L~ LE KSNV~g-~VP ~ 
fungal activities of recombinant and native drosomycin were I [ I I 1 I I compared by measuring the minimal inhibitory concentration I 
(MIC) on N. crassa, A. brassicola, F. culmorum and B. cinerea. Fig. 3. Amino-acid sequences of drosomycin and Rs-AFP1 (Rapha- 
The MIC values were found to be 0.3~.6, 0.6-1.2, 0.6-1.2 nus sativus antifungal peptide) and schematic representation f the 
and 1.2-2.5 gM, respectively, and were identical for both elements of the 3D structure of Rs-AFP1. Gaps introduced for opti- 
molecules. We extended the analysis of the activity spectrum mal alignment are indicated by dashes; boxed sequences represent 
13-strands. The 13-turn is underlined and the dashed line corresponds 
to several other fungal strains. Drosomycin exhibits antifungal to the c~-helix. Identical amino acids and conservative r placements 
activity against five of six fungal strains tested, with MIC are in bold-face. Disulfide bridges are indicated by the lines connect- 
values ranging from 0.3-0.6 BM against B. petunia and Verti- ing Cys pairs. Z represents the N-terminal pyroglutamate. 
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is apparent from the chromatogram (Fig. 2) that the bulk of somycin gene in flame with the preprocoding sequence of the 
drosomycin remained undigested, in keeping with our earlier MFatl gene. The fusion gene led to the expression and secre- 
results on the remarkable resistance ofdrosomycin to protease tion of four peptides: 25% of mature drosomycin, and three 
treatment [2]. Three minor peaks (referred to as 1-3 in Fig. 2) other molecules containing various N-terminal extensions cor- 
corresponded to digestion products (approximate yield of di- responding to the C-terminal part of the c~-factor prose- 
gestion: 1%). Mass spectrometry measurements of peak 1 quence. This indicates that the cleavage after the basic Lys- 
yielded two masses of 1527.9 and 1657.8 Da corresponding Arg dipeptide by the Kex2 endoprotease was rate-limiting. To 
to two potential cleavage fragments of drosomycin each con- test whether this could result from overloading of the secre- 
taining four cysteines engaged in two disulfide bridges. The tion pathway, we decided to overexpress the KEX2 gene con- 
difference of 129 Da between the two masses can be explained comitantly with the drosomycin gene. The yield of fully pro- 
by partial cleavage by endoproteinase Glu-C between the two cessed drosomycin was then increased from 25 to 90%. This 
C-terminal Glu residues. Peak 1 was submitted to sequencing clearly indicates that the amount of Kex2 endoprotease pres- 
by Edman degradation to confirm position of the disulfide ent in the yeast strain carrying pJM576 was insufficient o 
bridges. The results were as follows: Thr at cycle 1, cystine process the amount of drosomycin being made. The presence 
(Cys-Cys) and Trp at cycle 2, Arg at cycle 3, Arg and Glu at of 10% of an N-terminally extended form still recovered in 
cycle 4, Val at cycle 5, cystine at cycle 6, Lys and Glu, respec- spite of the overexpression of KEX2 may result either from 
tively, at cycles 7 and 8. In the case of the higher mass flag- the poor accessibility of the cleavage site between the c~-factor 
ment we detected a Glu residue at cycle 9. These data are in proregion and the mature drosomycin or from endoproteo- 
agreement with the sequence proposed in Fig. 2 (inset l) and lytic cleavage of the precursor, the product of which might no 
indicate that the disulfide bonds were CysVJ(3) Cysag(6) and longer be recognized by the Kex2 endoprotease. 
Cys23(4)-Cys'lt(7), knowing that in Edman degradation of With this system, the overall yield of expression and pur- 
peptide fragments linked by disulfide bridges, cysteine residues ification of drosomycin was of 2 mg of pure active peptide per 
are only set free as doublets. Peak 2 yielded two masses differ- 1 of culture medium (i.e. about 2× 101~ cells). Using the re- 
ing by 129 Da. i.e. the mass of the Glu residue. As presented combinant drosomycin, we extended the activity spectrum 
in Fig. 2 (inset 2), these masses can be explained by admitting studies of the molecule and showed that it exhibits a potent 
the connection of the fragment containing residues 1-8 of activity against fungal strains which are of major agronomic 
drosomycin to the peptide identified in peak 1 via a Cys2(l) interest, such as the wilt pathogen F. oxys'porum. We also 
to CyslL(8) link. Again, the enzyme endoproteinase GIu-C determined the disulfide bond array of the molecule, rein- 
imperfectly digested this compound as no cleav, age occurred forcing the similarities between drosomycin and the plant de- 
between residues Glu ~2 and Gly 13. Peak 3 also yielded two fensin Rs-AFPI ,  an antifungal peptide found in radish seeds 
masses differing by 129 Da, i.e. the mass of the Glu residue. [17,18]. The two molecules are aligned in Fig. 3 and show 38% 
The higher mass is in perfect agreement with the cleavage sequence identity following introduction of several minor 
product proposed in Fig. 2 (inset 3). Taken together, these gaps. Here we show that they share a common array of di- 
data are compatible with the following disulfide array: sulfide bridges (Cysl-Cys , Cys ~ Cysr', Cys 3 Cys !; and Cys ~ 
Cys2(I) CystiC(8), Cysll(2) Cys3:~(5), CysV)(3) Cys39(6) and CysT), extending the similarities from primary to secondary 
Cys23(4)-Cys~](7) which is identical to that determined for structure. The 3D structure of the plant defensin Rs-AFP1 
Raphanus defensin (Fig. 3). This array was confirmed on 80 from radish seeds has been determined by NMR studies: it 
~tg of native drosomycin extracted from 2000 immune-chal- is constituted by a triple-stranded antiparallel [3-sheet and an 
lenged adults of Drosophila. c~-helix parallel to the [3-sheet [18]. The determination of the 
tertiary structure of drosomycin is currently in progress, since 
4. Discussion the expression system described here provided sufficient 
amounts of pure peptide to undertake NMR studies. This 
The aim of the present study was to establish an expression will reveal whether the 3D structure of drosomycin is identical 
system for large-scale production of drosomycin for further to that of the plant defensin Rs-AFP1. 
investigations on its 3D structure, activity spectrum, and 
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